Dostarlimab-gxly Market to Expand at a CAGR of 15.6% during 2023-2031, Says Growth Plus Reports Newark, New Castle, USA, May 24, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global dostarlimab-gxly market was conducted by Growth Plus Reports in 2022. The market is expected to hit a...